Mar 7 |
BioAtla Announces Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
|
Dec 23 |
Co-Founder of BioAtla Jay Short Buys 2.3% More Shares
|
Dec 21 |
BioAtla CEO purchases 50K common shares
|
Dec 20 |
Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
|
Dec 20 |
BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
|
Dec 15 |
After losing 78% in the past year, BioAtla, Inc. (NASDAQ:BCAB) institutional owners must be relieved by the recent gain
|
Dec 13 |
BioAtla Hosting Virtual R&D Day to Highlight BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types
|
Dec 6 |
BioAtla to Host Virtual R&D Day to Review BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types on Wednesday, December 13, 2023
|
Dec 5 |
BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event
|
Nov 30 |
BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
|